Kathryn L. Wycislo - Concepedia

Author

Kathryn L. Wycislo

University of Illinois Urbana-Champaign ORCID

Also Known As

K. L. Wycislo, K.L. Wycislo, Kathryn L Wycislo, Kathryn L. Wycislo, Kathryn Wycislo

Publications

526

Citations

H-Index

Concepts

All Affiliations

University of Illinois Urbana-Champaign University of Illinois System Urbana University

About

Kathryn L. Wycislo is an author at University of Illinois Urbana-Champaign specializing in medicine, tumor biology, and cell biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	264
2	Cell Biology	3	3	249
3	Immunology	1	1	23
4	Pathology	1	1	35
5	Pharmacology	1	1	15

Kathryn L. Wycislo

Publications

353

Citations

H-Index

Page 1

	Year	Citations
Interfacial geometry dictates cancer cell tumorigenicity Junmin Lee, Amr A. Abdeen, Kathryn L. Wycislo, Nature Materials Malignant DiseaseTumor HeterogeneityInterfacial GeometryMatrix BiologyMedicine	2016	191
Comparative proteomic investigation of metastatic and non-metastatic osteosarcoma cells of human and canine origin Jahnabi Roy, Kathryn L. Wycislo, Holly C. Pondenis, PLoS ONE Proteomic TechnologyTumor BiologyNon-metastatic Osteosarcoma CellsPeptide FingerprintingMedicine	2017	35
Melanoma topology reveals a stem-like phenotype that promotes angiogenesis Junmin Lee, Amr A. Abdeen, Jamila Hedhli, Science Advances	2017	33
The Combination of Vemurafenib and Procaspase-3 Activation Is Synergistic in Mutant BRAF Melanomas Jessie Peh, Timothy M. Fan, Kathryn L. Wycislo, Molecular Cancer Therapeutics Braf MutationMutant Braf MelanomasMedicineReceptor Tyrosine KinaseMelanoma	2016	23
Pro-tumorigenic Effects of Transforming Growth Factor Beta 1 in Canine Osteosarcoma Roberta Portela, Bahaa Fadl-Alla, Holly C. Pondenis, Journal of Veterinary Internal Medicine	2014	21
Expression of Nociceptive Ligands in Canine Osteosarcoma Sharon Shor, Bahaa Fadl-Alla, Holly C. Pondenis, Journal of Veterinary Internal Medicine	2015	20
Downregulation of CXCR4 Expression and Functionality After Zoledronate Exposure in Canine Osteosarcoma Mark Byrum, Holly C. Pondenis, R.L. Fredrickson, Journal of Veterinary Internal Medicine	2016	15
Pharmacokinetics and derivation of an anticancer dosing regimen for the novel anti-cancer agent isobutyl-deoxynyboquinone (IB-DNQ), a NQO1 bioactivatable molecule, in the domestic felid species Alycen P. Lundberg, Joshua M. Francis, Malgorzata Zofia Pajak, Investigational New Drugs Pharmacological StudyNqo1 Bioactivatable MoleculeDomestic Felid SpeciesPharmacologyPharmacotherapy	2016	15

Page 1